Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX ... it is trading below the mean price target of $178.25. On the date of publication, Sohini Mondal did not have ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

Stocks gained and bond yields fell after the FOMC kept interest rates unchanged but projected two 25 bp interest rate cuts by the end of the year.  Stock gains accelerated Wednesday afternoon based on ...